Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 151–200 of 5,269 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04530552	Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland	completed	Phase 2	34	National Cancer Institute (NCI)NIH	1	Jun 25, 2026	clinicaltrials
NCT05185947	Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis	completed	Phase 2	21	National Cancer Institute (NCI)NIH	1	Jun 25, 2026	clinicaltrials